Physician profile
Neil E Strickman
NPI 1821190067
$57,037.71
in general payments reported to CMS, 2019-2025
50 companies · $17K in 2025
The $17K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $9,864 · 2021: $2,288 · 2022: $5,873 · 2023: $2,826 · 2024: $8,048 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $11K · Consulting Fee: $3,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,418.24 |
| Food and Beverage | $11,198.59 |
| Consulting Fee | $3,843.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,136.46 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Endurant Iis |
| Medtronic Vascular, INC. | $14,136.85 | 2019-2020 | |
| Edwards Lifesciences Corporation | $5,987.11 | 2019-2025 | Sapien 3 Ultra Resilia |
| Silk Road Medical, INC. | $4,064.08 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Penumbra, INC. | $2,636.88 | 2021-2022 | |
| Boston Scientific Corporation | $1,460.94 | 2019-2025 | Ekosonic, General - Angiography, General - Therapies |
| Angiodynamics, INC. | $1,132.28 | 2023-2024 | Angiovac, Alphavac |
| Inari Medical, INC. | $1,063.76 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Teleflex LLC | $886.39 | 2019-2025 | Manta, Guideliner |
| Pfizer INC. | $805.31 | 2019-2025 | |
| Endologix LLC | $802.80 | 2021-2022 | |
| Amgen INC. | $697.12 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $634.91 | 2021-2025 | Eliquis, Camzyos |
| Shockwave Medical, INC | $629.97 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $621.25 | 2019-2025 | Ensite Precision, Navitor, Cardiomems |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $610.42 | 2020-2025 | |
| Sirtex Medical INC | $550.00 | 2019 | |
| W. L. Gore & Associates, INC. | $396.01 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Saranas, INC. | $368.96 | 2021-2023 | |
| Abiomed | $361.86 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $311.16 | 2022-2024 | Optimizer, Optimizer |
| Inspiremd LTD | $263.34 | 2025 | Cguard Prime Carotid Stent System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $244.83 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $239.70 | 2021-2023 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $229.22 | 2021-2025 | Opsumit, Uptravi |
| Cardiva Medical, INC. | $215.96 | 2022-2024 | Savvywire, Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs |
| Cook Medical LLC | $167.56 | 2019 | |
| Biosense Webster, INC. | $149.72 | 2023-2024 | Carto 3 |
| Terumo Medical Corporation | $126.45 | 2023 | Glidesheath Slender, Tr Band, Optitorque |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.70 | 2022-2024 | Jardiance |
| Bridgebio Pharma, INC. | $109.90 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $97.51 | 2020-2024 | Wainua |
| Irhythm Technologies, INC. | $83.86 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $82.56 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $69.37 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $63.79 | 2022-2023 | |
| Esperion Therapeutics, INC. | $61.69 | 2021-2025 | Nexletol |
| Cardiovascular Systems INC. | $55.00 | 2019 | |
| Arrow International, INC. | $52.30 | 2019 | |
| Chiesi USA, INC. | $49.31 | 2019-2022 | |
| Heartflow, INC. | $45.45 | 2023 | Ffrct |
| Philips North America LLC | $43.29 | 2020-2024 | (Bh4) Igt Devices Undivided |
| Astellas Pharma US INC | $42.21 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $39.77 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $27.92 | 2024 | Arcalyst |
| Portola Pharmaceuticals, LLC | $21.41 | 2020 | |
| Contego Medical, INC | $18.50 | 2024 | |
| Avinger INC. | $15.26 | 2020 | |
| Elutia, INC. | $11.61 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,897.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Strickman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.